Project 1: The effects of cigarette package color on smoking behavior, exposure and risk perception when using low nicotine content cigarettes

项目总结 美国FDA有权监管香烟的尼古丁水平。尼古丁含量降低的香烟 减少依赖和毒物暴露，表明强制要求较低水平对公共健康有潜在好处 尼古丁产品标准。然而，这些发现主要来自于使用调查性LOW的研究 基本包装中的尼古丁含量香烟，没有附带的营销活动。因此，没有 目前可用来向监管部门通报这些产品如何销售的数据--这也是 FDA的权威，一个可能被烟草行业操纵的领域，以及一个潜在的机会 最大限度地发挥强制减少尼古丁的监管影响。在受监管的环境中，尼古丁 所有卷烟的含量都降低到相同的水平，烟草行业可能会依赖营销，以及 具体包装 含蓄地传达品牌吸引力、质量和健康诉求。该行业此前曾操纵 使用较浅颜色的包装来包装“轻”香烟，以错误地暗示这些产品 比普通香烟更有害。如果低尼古丁含量香烟使用类似的误导性包装，这可能会 营造减少危害的印象，通过增加产品使用减少尼古丁的好处 和曝光率。 控烟倡导者认为，普通包装应该减少吸烟者对烟草安全性的看法 某些彩色卷烟品牌，也可能会降低卷烟品牌的吸引力或满意度。然而， 研究还没有研究普通香烟包装在尼古丁含量 在香烟中的含量显著降低。因此，评估包装对吸烟者使用Low的影响的研究 香烟的尼古丁含量及其对有毒成分的暴露是烟草控制的关键。 在这些产品被授权和广泛销售之前做出政策决定。 该项目旨在评估低尼古丁含量香烟包装对两个主要结果的影响： 吸烟行为(即日常吸烟和吸烟行为)和生物毒物暴露。我们 还将探讨低尼古丁含量香烟包装如何影响产品风险认知和主观 评级，以确定这些结果是否中介包装对吸烟行为的影响。建议进行的研究 将首先检查低尼古丁含量卷烟在卷烟包装中使用的严格 结果的行为、生物、主观和心理面板。我们的香烟包装操纵 将审查烟草行业的方法和承诺的公共卫生倡议，这些倡议将提供必要的 为FDA未来的监管提供参考的经验证据。

PROJECT SUMMARY The US FDA has the authority to regulate cigarette nicotine levels. Cigarettes with reduced nicotine content decrease dependence and toxicant exposure, suggesting potential public health benefits of mandating a low nicotine product standard. These findings, however, come primarily from studies using investigational low nicotine content cigarettes in basic packaging with no accompanying marketing campaign. Thus, there is no data currently available to inform the regulation of how these products are marketed—a domain also under the FDA's authority, an area likely to be manipulated by the tobacco industry, and a potential opportunity to maximize the regulatory impact of mandated nicotine reduction. In a regulated environment where nicotine content is reduced to the same level across all cigarettes, the tobacco industry will likely rely on marketing, and specifically packaging—the “final communication vehicle”—to express brand image, promote sales, and implicitly convey brand attractiveness, quality and health appeals. The industry previously manipulated the packaging of “light” cigarettes using lighter colored packages to falsely imply that these products were less harmful than regular cigarettes. If low nicotine content cigarettes utilize similar misleading packaging, this may create perceptions of reduced harm that undermine benefits of nicotine reduction by increasing product use and exposure. Tobacco control advocates argue that plain packaging should decrease smokers' beliefs about the safety of certain colored cigarette brands, and may also make cigarette brands less appealing or satisfying. However, studies have not examined how plain cigarette packaging will affect smoking behaviors when nicotine content in the cigarette is significantly lowered. Thus, research evaluating packaging effects on smokers' use of low nicotine content cigarettes and their exposure to toxic constituents is critically needed to inform tobacco control policy decisions before these products are mandated and widely marketed. This project seeks to evaluate the effects of low nicotine content cigarette packaging on two primary outcomes: smoking behavior (i.e., daily cigarette consumption and puffing behavior) and biological toxicant exposure. We will also explore how low nicotine content cigarette packaging affects product risk perceptions and subjective ratings to determine if these outcomes mediate packaging effects on smoking behaviors. The proposed study will be the first to examine low nicotine content cigarettes in the context of cigarette packaging using rigorous behavioral, biological, subjective and psychological panels of outcomes. Our cigarette package manipulations will examine both tobacco industry approaches and promising public health initiatives that will provide essential empirical evidence to inform future FDA regulation.